NAFLD Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about NAFLD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Liver NeoplasmLiver FibrosisHBV Infection+1 more
Nanfang Hospital, Southern Medical University240 enrolled1 locationNCT07265544
Recruiting
Not Applicable

Prevalence of NAFLD in T1DM Patients

Type 1 DiabetesNAFLDFatty Liver, Nonalcoholic
Ziekenhuis Oost-Limburg138 enrolled1 locationNCT06445361
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting
Not Applicable

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

HypertensionTelemedicineDyslipidaemia+2 more
Changi General Hospital120 enrolled1 locationNCT06890169
Recruiting

Cardiac Dysfunction in Patients with Fatty Liver Disease

Cardiac DiseaseNAFLDFatty Liver+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh150 enrolled1 locationNCT06386094
Recruiting
Phase 1

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

Type 2 Diabetes Mellitus (T2DM)Non-alcoholic Fatty Liver Disease NAFLD
1Globe Health Institute52 enrolled1 locationNCT06694935
Recruiting

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

Cirrhosis, LiverHCCHBV+2 more
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis60 enrolled1 locationNCT05781568
Recruiting
Not Applicable

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins

NAFLDType2 Diabetes
Charite University, Berlin, Germany80 enrolled1 locationNCT04564391
Recruiting

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program

NAFLD (Nonalcoholic Fatty Liver Disease)PrediabetesDiabetes Mellitus Type 2, Diabetes Mellitus Type 1
Dasman Diabetes Institute2,000 enrolled1 locationNCT06115876
Recruiting

Biomarkers in the Diagnosis and Prognosis of NAFLD

ObesityDiabetes Mellitus, Type 2Liver Fibrosis+1 more
University of Trieste500 enrolled1 locationNCT06098417
Recruiting

The European NAFLD Registry

Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334
Recruiting

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Liver CancerObesityMetabolic Syndrome+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5,000 enrolled1 locationNCT04371042